Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 VENDOR SHARE ANALYSIS
2.9 MARKET TYPE OF MANUFACTURER COVERAGE GRID
2.1 MULTIVARIATE MODELLING
2.11 TEST TYPE LIFELINE CURVE
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 REGULATORY SCENARIO IN NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING EXPENDITURE ON DRUGS AND MEDICAL DEVICES
5.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN ANALYTICAL TESTING CAPABILITIES
5.1.3 INCREASING NUMBER OF DRUG APPROVALS & CLINICAL TRIALS
5.1.4 RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES
5.1.5 INCREASING INVESTMENT IN ANALYTICAL TESTING BY MARKET PLAYERS
5.2 RESTRAINTS
5.2.1 LIMITATION IN ANALYZING NOVEL COMPLEX PRODUCTS
5.2.2 COST OF LABORATORY TESTING FOR DRUG DEVELOPMENT
5.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT
5.2.4 HIGH COST SETTING AN ADVANCED ANALYTICAL LAB
5.3 OPPORTUNITIES
5.3.1 INCREASING COLLABORATION AMONG MARKET PLAYERS
5.3.2 INCREASING OUTSOURCING FACILITIES
5.3.3 INCREASING TREND OF ARTIFICIAL INTELLIGENCE IN TESTING SERVICES
5.4 CHALLENGES
5.4.1 MAINTAINING REGULATORY STANDARD FOR TESTING
5.4.2 DEVELOPMENT AND MAINTENANCE OF EXPERTISE
6 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE
6.1 OVERVIEW
6.2 CELL-BASED ASSAYS
6.3 VIRAL CELL-BASED ASSAYS
6.4 BACTERIAL CELL-BASED ASSAYS
6.5 VIROLOGY TESTING
6.6 IN VITRO VIROLOGY TESTING
6.7 IN VIVO VIROLOGY TESTING
6.8 SPECIES-SPECIFIC VIRAL PCR ASSAYS
6.9 SEROLOGY
6.1 IMMUNOGENICITY
6.11 BIOMARKER TESTING
6.12 PHARMACOKINETIC TESTING
7 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 BIOANALYTICAL TESTING
7.2.1 PHARMACOKINETIC TEST
7.2.2 PHARMACODYNAMICS TEST
7.2.3 BIOEQUIVALENCE TEST
7.2.4 BIOAVAILABILITY TEST
7.2.5 OTHER TEST
7.3 BATCH RELEASE TESTING
7.4 STABILITY TESTING
7.5 RAW MATERIAL TESTING
7.6 PHYSICAL CHARACTERIZATION
7.7 METHOD VALIDATION
7.8 MICROBIAL TESTING
7.9 ENVIRONMENTAL MONITORING
8 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 MASS SPECTROSCOPY (LC-MS/MS)
8.3 IMMUNOCHEMISTRY
8.4 UPLC TECHNOLOGY
8.5 TURBULENT FLOW TECHNOLOGY
8.6 OTHERS
9 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE
9.1 OVERVIEW
9.2 HOSPITAL-BASED LABORATORIES
9.3 STANDALONE LAORATORIES
9.4 CLINICS-BASED LABORATORIES
10 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ONCOLOGY
10.3 INFECTIOUS DISEASES
10.4 NEUROLOGY
10.5 CARDIOLOGY
10.6 GASTROENTEROLOGY
10.7 OTHER APPLICATIONS
11 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
11.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
11.4 CONTRACT RESEARCH ORGANIZATIONS
11.5 OTHERS
12 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 EUROFINS SCIENTIFIC
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 SERVICE PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 CHARLES RIVER LABORATORIES
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 SGS SA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 COVANCE (A SUBSIDIARY OF LABORATORY CORPORATION OF AMERICA HOLDINGS)
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 SERVICE PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 WUXI APPTEC
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 SYNEOS HEALTH
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 SOLUTION PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 PHARMACEUTICAL RESEARCH ASSOCIATES INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 SERVICE PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 AGENZIA ITALIANA DEL FARMACO - AIFA
15.8.1 COMPANY SNAPSHOT
15.8.2 SERVICE PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 ALS LIMITED
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 BIOAGILYTIX LABS
15.10.1 COMPANY SNAPSHOT
15.10.2 SERVICE PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 CENTRAL DRUGS STANDARD CONTROL ORGANIZATION
15.11.1 COMPANY SNAPSHOT
15.11.2 SERVICE PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 EUROPEAN MEDICINES AGENCY
15.12.1 COMPANY SNAPSHOT
15.12.2 SERVICE PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 EVOTEC SE
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 FEDERAL INSTITUTE FOR DRUGS & MEDICAL DEVICES (BFARM)
15.14.1 COMPANY SNAPSHOT
15.14.2 SERVICE PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 FOOD SAFETY AND DRUG ADMINISTRATION DEPARTMENT
15.15.1 COMPANY SNAPSHOT
15.15.2 SERVICE PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 FRONTAGE LABS
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 SERVICE & SOLUTION PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 ICON PLC
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENTS
15.18 INTERTEK GROUP PLC
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 INDUSTRY & SERVICE PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 MEDPACE
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 NATIONAL MEDICAL PRODUCTS ADMINISTRATION
15.20.1 COMPANY SNAPSHOT
15.20.2 SERVICE PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 PACE ANALYTICAL SERVICES, LLC
15.21.1 COMPANY SNAPSHOT
15.21.2 SERVICE PORTFOLIO
15.21.3 RECENT DEVELOPMENTS
15.22 PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENT
15.23 PPD INC. (A SUBSIDIARY OF THERMO FISHER SCIENTIFIC INC.)
15.23.1 COMPANY SNAPSHOT
15.23.2 REVENUE ANALYSIS
15.23.3 SOLUTION PORTFOLIO
15.23.4 RECENT DEVELOPMENTS
15.24 Q2 SOLUTIONS (A SUBSIDIARY OF IQVIA)
15.24.1 COMPANY SNAPSHOT
15.24.2 SOLUTION PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 SHANGHAI MEDICILON INC.
15.25.1 COMPANY SNAPSHOT
15.25.2 SERVICE PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 SPANISH AGENCY FOR MEDICINES AND HEALTH PRODUCTS
15.26.1 COMPANY SNAPSHOT
15.26.2 SERVICE PORTFOLIO
15.26.3 RECENT DEVELOPMENT
15.27 SOLVIAS AG
15.27.1 COMPANY SNAPSHOT
15.27.2 SERVICE PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
15.28 TOXIKON
15.28.1 COMPANY SNAPSHOT
15.28.2 SERVICE PORTFOLIO
15.28.3 RECENT DEVELOPMENTS
15.29 VXP PHARMA, INC.
15.29.1 COMPANY SNAPSHOT
15.29.2 SERVICE PORTFOLIO
15.29.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA CELL-BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA SEROLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA IMMUNOGENICITY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA BIOMARKER TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA PHARMACOKINETIC TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA BIOANALYTICAL IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA BATCH RELEASE IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA STABILITY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA RAW MATERIAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA PHYSICAL CHARACTERIZATION IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA METHOD VALIDATION IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA MICROBIAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA ENVIRONMENTAL MONITORING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA MASS SPECTROMETRY (LC-MS/MS) IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA IMMUNOCHEMISTRY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA UPLC TECHNOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA TURBULENT FLOW TECHNOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA OTHERS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA HOSPITAL-BASED LABORATORIES IN ANALYTICAL LABORATORIES SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA STANDALONE LABORATORIES IN ANALYTICAL LABORATORIES SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA CLINICAL-BASED LABORATORIES IN ANALYTICAL LABORATORIES SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA ONCOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA INFECTIOUS DISEASES IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA NEUROLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA CARDIOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA GASTROENTEROLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA OTHER APPLICATIONS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA OTHERS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 52 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 53 U.S. BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 54 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)
TABLE 55 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 56 U.S. CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 57 U.S. VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 58 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 59 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 60 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 62 CANADA BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 63 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)
TABLE 64 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 65 CANADA CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 66 CANADA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 67 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 68 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 69 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 71 MEXICO BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 72 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)
TABLE 73 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 74 MEXICO CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 75 MEXICO VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)
TABLE 76 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 77 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 78 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: MARKET TYPE COVERAGE GRID
FIGURE 10 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: MULTIVARIATE MODELLING
FIGURE 11 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 12 GROWING EXPENDITURE ON DRUGS IS DRIVING THE NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 ANALYTICAL LABORATORY TESTING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET IN 2022 & 2029
FIGURE 14 OVERVIEW OF DIFFERENT GUIDELINES AROUND THE GLOBE
FIGURE 15 CGMP REQUIREMENT FOR ANALYTICAL LABORATORY INCLUDES
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET
FIGURE 17 INCREASING PRESCRIPTION OF DRUGS
FIGURE 18 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2021
FIGURE 19 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY METHOD TYPE, 2021-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY METHOD TYPE, CAGR (2021-2029)
FIGURE 21 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY METHOD TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2021
FIGURE 23 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE 2021-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE, CAGR (2021-2029)
FIGURE 25 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021
FIGURE 27 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TECHNOLOGY, 2021-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TECHNOLOGY, CAGR (2021-2029)
FIGURE 29 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 30 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2021 (USD MILLION)
FIGURE 31 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2021-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2029)
FIGURE 33 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 34 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2021 (USD MILLION)
FIGURE 35 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2021-2029 (USD MILLION)
FIGURE 36 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2021-2029)
FIGURE 37 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION , LIFELINE CURVE
FIGURE 38 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2021
FIGURE 39 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY END USER, 2021-2029 (USD MILLION)
FIGURE 40 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY END USER, CAGR (2021-2029)
FIGURE 41 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: SNAPSHOT (2021)
FIGURE 43 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021)
FIGURE 44 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE (2022-2029)
FIGURE 47 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)
